Dave Coulier has been diagnosed with HPV-related tongue cancer, just months after going into remission from stage 3 ...

Dave Coulier has revealed that he is undergoing treatment for tongue cancer, just a year after he beat non-Hodgkin lymphoma.

Citius Oncology launches US FDA approved Lymphir, a novel cancer immunotherapy for cutaneous T-cell lymphoma: Cranford, New Jersey Wednesday, December 3, 2025, 16:00 Hrs [IST] Cit ...

“LYMPHIR is an important new treatment option for the CTCL community, and its launch marks the beginning of a new chapter for ...

At 22, Emma Operacz found out she had stage 4 T-cell lymphoma. Now, she wants to give back to others facing a similar ...

JAK2 gene fusion appears across multiple CTCL types, shaping diagnosis and treatment opportunities. Learn more about its ...

XPOVIO® (selinexor) has received approvals for three indications in Hong Kong. These include its previous approval as the ...

Dave Coulier’s new tongue cancer diagnosis raises questions about whether it’s linked to his prior lymphoma. Experts explain the risks, causes, and why second primary cancers can occur.

Actor Dave Coulier has revealed a new tongue cancer diagnosis just months after beating lymphoma. The 66-year-old “Full House ...

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced updated data from the LOTIS-7 Phase 1b open-label ...

Biotech veteran with over 25 years of business development, strategy and operational experience joins March Bio’s management team HOUSTON, Dec. 03, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March ...

ImmunityBio delivered strong 3Q25 results, with Anktiva driving 434% YoY product revenue growth and a narrowed operating loss ...